InsidersTradesSigma
昭栄薬品株式会社: directors' dealings · Japan · EDINET (Japan FSA)
EDINET:company-a0aee6JP·EDINET (Japan FSA)Mcap 5.6Bn€Basic Materials
Explore the full directors' dealings record of 昭栄薬品株式会社, a listed equity based in Japan. Shares are listed on JP JP, under the oversight of EDINET (Japan FSA). Operating in the Basic Materials sector, 昭栄薬品株式会社 has published 2 insider filings. Market capitalisation: €5.6bn. The latest transaction was disclosed on 8 May 2023 — Holding update. Among the most active insiders: Hikari Tsushin K.K.. The full history is free.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
1636.00 €
Analyst consensus
Income statement
Revenue25.01 Bn€
Gross profit2.10 Bn€8% margin
Net income527.4 M€2.1% margin
Valuation
PER (trailing)11.5x
P/Book0.6x
Balance sheet & cash
Market cap5.60 Bn€
Total debt600.0 M€
Free Cash Flow−179.4 M€
Debt / Equity2%
Profitability & ownership
ROE6.1%
ROA1.8%
% insiders36.9%
% institutions8.6%
Last declaration on 8 May 2023
Declarations2 total
Executives●Holding update13EDINET
€1m45.0% of flow
ShareXTKS
EDINET:S100QOU3·
Executives●Holding update15EDINET
€2m55.0% of flow
ShareXTKS
EDINET:S100Q1PL·
2 of 2 declarations